- Home
- GTBP vs PMAX Comparison
GTBP vs PMAX Comparison
Compare GTBP & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- PMAX
- Stock Information
- Founded
- GTBP 1965
- PMAX 2019
- Country
- GTBP United States
- PMAX Hong Kong
- Employees
- GTBP N/A
- PMAX N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- PMAX
- Sector
- GTBP Health Care
- PMAX
- Exchange
- GTBP Nasdaq
- PMAX Nasdaq
- Market Cap
- GTBP 5.5M
- PMAX 6.0M
- IPO Year
- GTBP N/A
- PMAX 2024
- Fundamental
- Price
- GTBP $0.73
- PMAX $2.87
- Analyst Decision
- GTBP Strong Buy
- PMAX
- Analyst Count
- GTBP 1
- PMAX 0
- Target Price
- GTBP $11.00
- PMAX N/A
- AVG Volume (30 Days)
- GTBP 641.6K
- PMAX 90.1K
- Earning Date
- GTBP 11-13-2025
- PMAX 09-23-2025
- Dividend Yield
- GTBP N/A
- PMAX N/A
- EPS Growth
- GTBP N/A
- PMAX N/A
- EPS
- GTBP N/A
- PMAX N/A
- Revenue
- GTBP N/A
- PMAX $4,799,100.00
- Revenue This Year
- GTBP N/A
- PMAX N/A
- Revenue Next Year
- GTBP N/A
- PMAX N/A
- P/E Ratio
- GTBP N/A
- PMAX N/A
- Revenue Growth
- GTBP N/A
- PMAX N/A
- 52 Week Low
- GTBP $0.55
- PMAX $1.87
- 52 Week High
- GTBP $4.10
- PMAX $31.92
- Technical
- Relative Strength Index (RSI)
- GTBP 35.99
- PMAX 91.41
- Support Level
- GTBP $0.62
- PMAX $0.26
- Resistance Level
- GTBP $0.68
- PMAX $0.29
- Average True Range (ATR)
- GTBP 0.08
- PMAX 0.15
- MACD
- GTBP 0.03
- PMAX 0.26
- Stochastic Oscillator
- GTBP 45.39
- PMAX 84.69
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.